DMCRN-02-001: Assessing Pediatric Endpoints in DM1

Recruiting now

Conditions studied: Congenital Myotonic Dystrophy, CDM

In brief

The overall goal of the study is to establish valid clinical endpoint assessments for children with congenital myotonic dystrophy type 1 and develop biomarkers for the condition.

Key facts

Study ID
NCT05224778
Run by
Virginia Commonwealth University
People needed
50
Starts
2022-08-24
Expected to finish
2026-12-01
Last updated by the study team
2026-06-10

Who can join

Age: any, up to 5. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.